PHRMA

America’s biopharmaceutical research companies support the new health care reform law because it can help improve patient care, make treatments more readily available to patients and help millions of uninsured Americans access health care coverage and services. It also provides some important incentives for future medical innovation.

With health care costs rising significantly over the years – attributed in many ways to chronic disease and expensive emergency care services – and millions of patients unable to afford insurance or denied the ability to purchase coverage because of pre-existing illness, reform was sorely needed.

When President Obama asked many different health care stakeholders to make sacrifices and offer financial support to help pay  (read more)